An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Condition:   Wegener's Granulomatosis, Microscopic PolyangiitisIntervention:   Sponsor:   Genentech, Inc.Active, not recruiting - verified December 2014

Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials